Anika Therapeutics, Inc. Defined Contribution Plan, Cost
Anika Therapeutics, Inc. (ANIK) reported Defined Contribution Plan, Cost of $362.15 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2014-03-13
- Anika Therapeutics, Inc. defined contribution plan, cost for fiscal 2013 was $362.15K, a 11.09% increase from fiscal 2012.
- Anika Therapeutics, Inc. defined contribution plan, cost for fiscal 2012 was $326.01K, a 16.51% increase from fiscal 2011.
- Anika Therapeutics, Inc. defined contribution plan, cost for fiscal 2011 was $279.82K, a 3.88% decline from fiscal 2010.
- Anika Therapeutics, Inc. defined contribution plan, cost for fiscal 2010 was $291.11K.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2013-12-31 | $362.15K 10-K · filed 2014-03-13 |
| 2012-12-31 | $326.01K 10-K · filed 2014-03-13 |
| 2011-12-31 | $279.82K 10-K · filed 2014-03-13 |
| 2010-12-31 | $291.11K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |